The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial - Kanozawa, K; Noguchi, Y; Sugahara, S (Clin Exp Nephrol, 2018)